Simultaneous Determination of Eight Nitrosamine Impurities in Metformin Using the Agilent 6470 Triple Quadrupole LC/MSApplications | 2020 | Agilent TechnologiesInstrumentationLC/MS, LC/MS/MS, LC/QQQIndustriesPharma & BiopharmaManufacturerAgilent TechnologiesKey wordsnitrosamine, nmpa, ndipa, ndpa, nmba, neipa, ndba, ndea, ndma, impurities, quantifier, qualifier, concentration, responses, drug, metformin, eight, determination, impurity, apci, respect, bracketing, losartan, recall, arb, triple, mrm, products, actual, test, medicines, method, receptor, ion, press, fda, reproducibility, hrms, acknowledgement, wrt, substance, announcementsangiotensin, arbrecalls, fdaupdates, statementalerting, name, careprofessionals, development, announcements, quadrupole
Similar PDF
Nitrosamine Impurities Application Guide - Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products
2020|Agilent Technologies|GuidesPresentations
Nitrosamine ImpuritiesApplication GuideConfidently Detect and QuantifyMutagenic Impurities in APIs andDrug Products Sartan-BasedLosartan ValsartanCandesartan TelmisartanMetforminRanitidineNitrosamines are formed by chemical reactions that occur during APImanufacturing whether from starting materials, intermediates, reactants, reuse ofsolvents and by-products; they can form through degradation products generatedduring formulation...
Key words
back, backndma, ndmaneipa, neipafda, fdandipa, ndipandea, ndeandba, ndbametformin, metforminnitrosamine, nitrosamineintroduction, introductionapi, apibest, bestvalsartan, valsartancandesartan, candesartantelmisartan
Simultaneous Determination of Eight Nitrosamine Impurities in Metformin Extended-Release Tablets Using the Agilent 6470 Triple Quadrupole LC/MS
2020|Agilent Technologies|Applications
Application NotePharmaceutical SmallMoleculesSimultaneous Determination of EightNitrosamine Impurities in MetforminExtended-Release Tablets Using theAgilent 6470 Triple Quadrupole LC/MSDetection of regulated genotoxic impurities from thedrug manufacturing processAuthorsChander Mani,Kartheek Srinivas Chidella,Saikat Banerjee, andSamir VyasAgilent Technologies, Inc.AbstractDetermination of nitrosamine impurities in drug substances and drug...
Key words
nitrosamine, nitrosaminenmpa, nmpandipa, ndipandpa, ndpandba, ndbaneipa, neipanmba, nmbandea, ndeaimpurities, impuritiesndma, ndmaresponses, responsesmetformin, metformindrug, drugeight, eightconcentration
Quantitation of 8 Nitrosamines in 12 different solvents by LC-MS/MS system
2021|Shimadzu|Applications
Liquid Chromatograph Mass Spectrometer LCMSTM-8045ApplicationNewsQuantitation of 8 Nitrosamines in 12 differentsolvents by LC-MS/MS systemShailendra Rane1 , Devika Tupe1 , Deepti Bhandarkar1, Jeetendra Kelkar1 and Pratap Rasam11 Shimadzu Analytical (India) Pvt. Ltd.User Benefits◆ A single LC-MS/MS method for the determination of...
Key words
nmpa, nmpandma, ndmanmba, nmbaistd, istdndipa, ndipandpa, ndpandba, ndbandea, ndeadmf, dmfratio, ratiotarget, targetnitrosamines, nitrosaminesneipa, neipaarea, areansa
Detection and Quantitation of Nitrosamine Impurities in Drug Substances by LC-HRMS on LCMS-9030
2021|Shimadzu|Applications
Nitrosamine impurities in drug substances / LCMSTM-9030ApplicationNewsDetection and Quantitation of Nitrosamine Impuritiesin Drug Substances by LC-HRMS on LCMS-9030Zhaoqi Zhan1, Zhe Sun1, Deepti Bhandarkar2, Shailendra Rane2, Pratap Rasam2, Jitendra Kelkar2(Asia Pacific) Pte Ltd, 2 Shimadzu Analytical (India) Pvt Ltd1 ShimadzuUser Benefits◆...
Key words
ndma, ndmandea, ndeanmba, nmbaneipa, neipandipa, ndipandba, ndbandpa, ndpanmpa, nmpametformin, metforminnitrosamines, nitrosaminesdrug, drugppm, ppmloq, loqlosartan, losartanarb